CJC-1295 with DAC – 2 mg

Long-acting GHRH analog for sustained growth hormone release

Heather

Last Update hace 10 meses

Category:
Growth Hormone Support / Recovery / Anti-Aging


Primary Benefits:

  • Sustained elevation of growth hormone (GH) and IGF-1

  • Enhances lean muscle growth and fat metabolism

  • Supports recovery, sleep quality, and collagen synthesis

  • Reduces injection frequency (1–2x/week)

  • Promotes cellular repair and anti-aging effects



Mechanism of Action:

CJC-1295 with DAC (Drug Affinity Complex) is a modified growth hormone–releasing hormone (GHRH) analog. The DAC extends its half-life to approximately 6–8 days by allowing it to bind to albumin in the bloodstream. This enables a prolonged and stable GH release, elevating IGF-1 levels without daily injections. It’s best used solo or cycled with shorter-acting GHRPs like Ipamorelin.


Dosing & Protocol:

Subcutaneous (SQ) Injection:

• Reconstitution:
 – 2 mg vial → 2.0 ml bacteriostatic water

• Weekly Dose:
 – 100–300 mcg (20–30 units), taken twice per week

• Cycle:
 2 days per week
 20 weeks on, followed by 4–6 weeks off

• Timing:
 Inject on an empty stomach, preferably in the evening


Potential Side Effects:

  • Mild water retention or bloating

  • Temporary tingling in hands or feet

  • Slight flu-like symptoms in rare cases

  • Not recommended to combine with other long-acting GH analogs


Common Stacks:

  • Solo: For those wanting minimal injection frequency

  • With TB-500 or BPC-157: For injury and post-surgery recovery

  • With Epithalon: For synergistic anti-aging and cellular rejuvenation


Notes:

Because of its long half-life, CJC-1295 with DAC should not be used daily. Overlapping with other long-acting GH secretagogues may lead to receptor fatigue or downregulation. It’s ideal for users wanting a low-maintenance growth hormone protocol. Store reconstituted vials in the refrigerator and discard after 30–45 days.


Disclaimer:
The information provided in this article is for educational and informational purposes only and is not intended as medical advice. These statements have not been evaluated by the FDA or Health Canada. Peptides and other compounds discussed are intended for research purposes only and are not approved for human consumption unless prescribed by a licensed medical professional. Always consult your healthcare provider before starting any new protocol, supplement, or treatment.

Was this article helpful?

0 out of 0 liked this article